Global distribution of respiratory syncytial virus A and B infections: a systematic review.
Respiratory syncytial virus
epidemiology
genotype
molecular epidemiology
respiratory viruses
Journal
Pathogens and global health
ISSN: 2047-7732
Titre abrégé: Pathog Glob Health
Pays: England
ID NLM: 101583421
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
pubmed:
15
2
2022
medline:
24
9
2022
entrez:
14
2
2022
Statut:
ppublish
Résumé
Respiratory syncytial virus (RSV) is the main cause of severe respiratory infections in young children. The need for global epidemiologic data regarding RSV has been increasingly recognized. RSV A infections are reported more frequently than RSV B. Nonetheless, the temporal distribution of infections caused by both RSV groups has not been investigated globally. A systematic review was carried out regarding published studies on RSV A and B epidemiology, as well as RSV G gene ectodomain sequence data available at GenBank. A total of 76,668 [45,990 (60%) RSV A and 30,678 (40%) RSV B] positive samples from 83 countries were identified and included in the analysis. Genotype assignment was obtained in 5,340 RSV A and 2,518 RSV B sequences. Two patterns of RSV circulation were observed: continuous seasons with RSV A predominance and alternate predominance of RSV A and B. These patterns were observed in all regions, but the predominant RSV group seldom coincided in all continents during a given year or season. The most frequently identified RSV A genotype was NA1 (including ON1 viruses) (76.30%), and the most frequently identified RSV B genotype was BA (70.65%). Multiple genotypes circulated simultaneously throughout the evolutionary history of RSV, but genotype diversity decreased after the year 2000. The classification of RSV group and genotype is important for the development of vaccines, as well as to understand viral dynamics. This study displays the global and continental RSV circulation patterns from the first report of human RSV infection until the end of 2020.
Identifiants
pubmed: 35156555
doi: 10.1080/20477724.2022.2038053
pmc: PMC9518599
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
398-409Références
PLoS One. 2015 Jun 05;10(6):e0129369
pubmed: 26047100
J Infect Dis. 2020 Sep 14;222(8):1298-1310
pubmed: 32591787
J Clin Virol. 2020 Aug;129:104506
pubmed: 32585620
J Clin Microbiol. 1996 Feb;34(2):334-7
pubmed: 8789010
J Infect Dis. 2013 Dec 15;208 Suppl 3:S227-37
pubmed: 24265482
J Infect Dis. 2018 Mar 13;217(7):1089-1098
pubmed: 29373744
Microorganisms. 2020 Dec 21;8(12):
pubmed: 33371276
PLoS One. 2012;7(3):e32807
pubmed: 22470426
J Infect Dis. 2018 Apr 11;217(9):1356-1364
pubmed: 29390105
PLoS One. 2016 Nov 11;11(11):e0166145
pubmed: 27835664
Emerg Infect Dis. 2014 Jun;20(6):950-9
pubmed: 24856417
Am J Hyg. 1957 Nov;66(3):281-90
pubmed: 13478578
J Virol. 2010 Aug;84(15):7500-12
pubmed: 20504933
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Arch Virol. 2020 May;165(5):1069-1077
pubmed: 32144544
Sci Rep. 2019 Mar 18;9(1):4704
pubmed: 30886248
PLoS One. 2018 Jan 29;13(1):e0192085
pubmed: 29377949
Sci Rep. 2021 Feb 10;11(1):3452
pubmed: 33568737
Sci Rep. 2019 Dec 27;9(1):20097
pubmed: 31882808
J Gen Virol. 2003 Nov;84(Pt 11):3115-3120
pubmed: 14573817